October 2015 Briefing – Allergy
Here are what the editors at HealthDay consider to be the most important developments in Allergy for October 2015. This roundup includes the latest...
Nasal Congestion No Better With Phenylephrine in Allergic Rhinitis
Doses up to 40 mg of phenylephrine hydrochloride not linked to significant improvement
Displaying Prices to Providers Seems to Reduce Order Costs
Review shows price display decreases aggregate order costs more frequently than order volume
Competition for Fellowships Broke Records in 2015
One-quarter of applicants did not didn't receive a position
Prescribing Drugs ‘Off-Label’ Can Pose Serious Safety Risks
Study raises concerns about using meds to treat conditions for which they weren't approved
Increasing Numbers of Med School Applicants, Enrollees
Med school classes continuing to diversify, with increases in nearly every racial/ethnic category
Synchronized Prescription Renewal Process Saves Time
Renewing all patient's stable medications for 12 to 15 months can save time and money
Sanofi Recalls Auvi-Q Injectors Used to Treat Anaphylaxis
Injectors may not deliver right amount of drug
LABAs No Better Than Tiotropium in Black Adults With Asthma
Outcomes similar for patients treated with inhaled corticosteroids plus tiotropium versus LABAs
Nearly 15 Percent of Plans Lack In-Network Specialists
Most commonly excluded specialists are in endocrinology, rheumatology, and psychiatry
